Summary of Study ST000164

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench,, where it has been assigned Project ID PR000142. The data can be accessed directly via it's Project DOI: 10.21228/M8MG6K This work is supported by NIH grant, U2C- DK119886.


Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST000164
Study TitleMetabolomic analysis of normal and diabetic mouse bone marrow under PBS or metformin treatment
Study TypeUntargeted Metabolomics
Study SummaryWild type and diabetic (MKR) mice were treated daily with intraperitoneal injections of 50 microliters of PBS (control) or metformin (200 mg/kg body weight) for 14 days. Their bone marrow cells were collected and compared by untargeted metabolomics.
New York University
DepartmentCollege of Dentistry, Basic Science and Craniofacial Biology
LaboratoryXin Li Laboratory
Last NameXin
First NameLi
Address345 East 24th Street, Room 901D, New York, NY 10010
Submit Date2015-03-04
Num Groups4
Total Subjects15 samples
Study Commentseach sample with 3 technical replicates in each mode
Raw Data AvailableYes
Raw Data File Type(s)raw(Thermo)
Uploaded File Size7.1 G
Analysis Type DetailLC-MS
Release Date2016-12-22
Release Version1
Li Xin Li Xin application/zip

Select appropriate tab below to view additional metadata details:


Project ID:PR000142
Project DOI:doi: 10.21228/M8MG6K
Project Title:Bone marrow metabolomics of MKR mice under metformin treatment
Project Type:Untargeted Metabolomics on metformin responses in bone marrows of diabetic mice
Institute:New York University
Department:College of Dentistry, Basic Science and Craniofacial Biology
Laboratory:Xin Li Laboratory
Last Name:Xin
First Name:Li
Address:345 East 24th Street, Room 901D, New York, NY 10010
Funding Source:NIH grants R01CA180277, CA172894, 5R01GM06248012-12, NIDDK grant 3U54DK10255602S2, California Institute for Regenerative Medicine grant RB4-06087.